Loading...
Loading...
TRIB| Name | Value |
|---|---|
| Revenues | 13.9M |
| Cost of Revenue | 8.9M |
| Gross Profit | 5.0M |
| Operating Expense | 9.1M |
| Operating I/L | -14.9M |
| Other Income/Expense | -3.8M |
| Interest Income | 0.1M |
| Pretax | -18.6M |
| Income Tax Expense | -0.3M |
| Net Income/Loss | -6.0M |
Trinity Biotech plc is a medical diagnostic products company that focuses on the clinical laboratory and point-of-care segments of the diagnostic market. The company offers a range of diagnostic tests and instrumentation for detecting infectious diseases, including Lyme disease, sexually transmitted diseases, SARS-CoV-2, and various viral pathogens. Additionally, it provides in-vitro diagnostic testing for haemoglobin A1c used in diabetes monitoring and diagnosis. Trinity Biotech also develops and sells products in various assay formats and offers reagent products for the diagnosis of liver and kidney diseases, as well as haemolytic anaemia.
